UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549


 
FORM 8-K


 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 30, 2015


 
ACUCELA INC.
(Exact name of registrant as specified in its charter)


 


 
 
 
 
 
Washington
 
000-5513
 
02-0592619
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)
1301 Second Avenue, Suite 4200
Seattle, Washington 98101
(Address of principal executive offices, including zip code)
(206) 805-8300
(Registrant’s telephone number, including area code)
Not applicable.
(Former name or former address, if changed since last report)


 





Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))






Item 8.01
Other Events.
On March 31, 2015 (Japan Standard Time) Acucela Inc. announced that its 2015 Annual Meeting of Shareholders, previously scheduled for Monday, June 8, 2015 at 1:00PM (Pacific Daylight Time) for shareholders of record as of March 31, 2015, will be held on Thursday, June 25, 2015 at Acucela’s headquarters in Seattle, Washington at 2:00PM (Pacific Daylight Time) for shareholders of record as of April 20, 2015.

The date of the meeting was moved to provide enough time to incorporate the results of the special shareholders meeting on May 1, 2015 into the proxy materials.





        



SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

 
 
 
 
ACUCELA INC.
 
 
 
 
By:
/s/ Brian O’Callaghan
 
 
Brian O’Callaghan
Date: March 30, 2015
 
President